| Patent | Date |
|---|
Cross-species-specific Single Domain Bispecific Single Chain Antibody
App 20220041736 - Kufer; Peter ; et al. | 2022-02-10 |
Antibody Constructs For Dll3 And Cd3
App 20210309743 - Raum; Tobias ; et al. | 2021-10-07 |
Antibody Constructs For Cd70 And Cd3
App 20210284748 - Raum; Tobias ; et al. | 2021-09-16 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20210277143 - KUFER; Peter ; et al. | 2021-09-09 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20210269550 - KUFER; Peter ; et al. | 2021-09-02 |
Bispecific antibody constructs for CDH3 and CD3
Grant 11,028,171 - Weiss , et al. June 8, 2 | 2021-06-08 |
Cross-species-specific single domain bispecific single chain antibody
Grant 10,981,998 - Kufer , et al. April 20, 2 | 2021-04-20 |
Antibody constructs for CD70 and CD3
Grant 10,851,170 - Raum , et al. December 1, 2 | 2020-12-01 |
Cross-species-specific Pscaxcd3, Cd19xcd3, C-metxcd3, Endosialinxcd3, Epcamxcd3, Igf-1rxcd3 Or Fapalphaxcd3 Bispecific Single Chain Antibody
App 20200362039 - Kufer; Peter ; et al. | 2020-11-19 |
Antibody Constructs For Dll3 And Cd3
App 20200332002 - Raum; Tobias ; et al. | 2020-10-22 |
Antibody constructs for DLL3 and CD3
Grant 10,683,351 - Raum , et al. | 2020-06-16 |
Cross-species-specific Bispecific Binders
App 20200095319 - Kufer; Peter ; et al. | 2020-03-26 |
Antibody Constructs For Cdh19 And Cd3
App 20200071405 - Xiao; Shouhua ; et al. | 2020-03-05 |
Single chain binding molecules comprising N-terminal ABP
App 20200040099 - Kufer; Peter ; et al. | 2020-02-06 |
Antibody Constructs For Dll3 And Cd3
App 20190263907 - Raum; Tobias ; et al. | 2019-08-29 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20190169310 - Kufer; Peter ; et al. | 2019-06-06 |
Long Life Polypeptide Binding Molecules
App 20190169295 - Kufer; Peter ; et al. | 2019-06-06 |
Antibody constructs for DLL3 and CD3
Grant 10,294,300 - Raum , et al. | 2019-05-21 |
Antibody Constructs For Cdh19 And Cd3
App 20190016805 - Xiao; Shouhua ; et al. | 2019-01-17 |
Antibody constructs for CDH19 and CD3
Grant 10,059,766 - Xiao , et al. August 28, 2 | 2018-08-28 |
Pharmaceutical compositions with resistance to soluble CEA
Grant 9,982,063 - Lutterbuse , et al. May 29, 2 | 2018-05-29 |
Bispecific Antibody Constructs For Cdh3 And Cd3
App 20180142021 - Weiss; Bertram ; et al. | 2018-05-24 |
Antibody Constructs For CDH19 and CD3
App 20180002450 - Xiao; Shouhua ; et al. | 2018-01-04 |
Optimized Cross-species Specific Bispecific Single Chain Antibody Contructs
App 20170349668 - Rattel; Benno ; et al. | 2017-12-07 |
Antibody constructs for CDH19 and CD3
Grant 9,765,157 - Xiao , et al. September 19, 2 | 2017-09-19 |
Pharmaceutical compositions with resistance to soluble CEA
Grant 9,695,250 - Lutterbuse , et al. July 4, 2 | 2017-07-04 |
Pharmaceutical Compositions With Resistance To Soluble Cea
App 20170137538 - Lutterbuse; Ralf ; et al. | 2017-05-18 |
Antibody Constructs For Cd70 And Cd3
App 20170129961 - Raum; Tobias ; et al. | 2017-05-11 |
Antibody Constructs For Dll3 And Cd3
App 20170037130 - Raum; Tobias ; et al. | 2017-02-09 |
Cross-species-specific Bispecific Binders
App 20160152707 - Kufer; Peter ; et al. | 2016-06-02 |
Antibody constructs for CDH19 and CD3
App 20160032019 - Xiao; Shouhua ; et al. | 2016-02-04 |
Antibody Constructs for CDH19 and CD3
App 20140322218 - Xiao; Shouhua ; et al. | 2014-10-30 |
Pharmaceutical Compositions With Resistance To Soluble Cea
App 20130273050 - LUTTERBUSE; Ralf ; et al. | 2013-10-17 |
Pharmaceutical compositions with resistance to soluble CEA
Grant 8,394,926 - Lutterbuse , et al. March 12, 2 | 2013-03-12 |
Cross-species-specific Bispecific Binders
App 20120244162 - KUFER; Peter ; et al. | 2012-09-27 |
CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20120034228 - Kufer; Peter ; et al. | 2012-02-09 |
Less immunogenic binding molecules
Grant 8,101,722 - Kufer , et al. January 24, 2 | 2012-01-24 |
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
App 20110293619 - Kufer; Peter ; et al. | 2011-12-01 |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
Grant 7,635,472 - Kufer , et al. December 22, 2 | 2009-12-22 |
Pharmaceutical Compositions With Resistance To Soluble Cea
App 20090226432 - Lutterbuse; Ralf ; et al. | 2009-09-10 |
CD19xCD3 specific polypeptides and uses thereof
Grant 7,575,923 - Dorken , et al. August 18, 2 | 2009-08-18 |
Method of identifying binding site domains that retain the capacity of binding to an epitope
Grant 7,435,549 - Kufer , et al. October 14, 2 | 2008-10-14 |
Less Immunogenic Binding Molecules
App 20080213256 - Kufer; Peter ; et al. | 2008-09-04 |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
App 20070123479 - Kufer; Peter ; et al. | 2007-05-31 |
CD 19.times.CD3 specific polypeptides and uses thereof
Grant 7,112,324 - Dorken , et al. September 26, 2 | 2006-09-26 |
Novel CD19xCD3 specific polypeptides and uses thereof
App 20060193852 - Dorken; Bernd ; et al. | 2006-08-31 |
Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
App 20040038339 - Kufer, Peter ; et al. | 2004-02-26 |
| 